Indo-Bangla Pharmaceuticals Limited (DSE:IBP)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
12.30
-0.20 (-1.60%)
At close: Mar 27, 2025
-27.22%
Market Cap 1.43B
Revenue (ttm) 119.08M
Net Income (ttm) -44.98M
Shares Out 116.21M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend 0.01 (0.08%)
Ex-Dividend Date Dec 4, 2024
Volume 760,070
Average Volume 2,537,245
Open 12.60
Previous Close 12.50
Day's Range 12.30 - 12.60
52-Week Range 6.80 - 17.00
Beta 0.05
RSI 55.31
Earnings Date Apr 30, 2025

About DSE:IBP

Indo-Bangla Pharmaceuticals Limited engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally. Its principal products include analgesics and antipyretics, anthelmintic, anti-asthmatic, gastroprokinetic and antiemetic, antiprotozoal, non-hormone sex stimulant, non-steroidal, anti-inflammatory, steroids, and vitamins and minerals, as well as respiratory, cardiovascular, central nervous system, dermatology, and gastrointestinal categories. The company markets its products ... [Read more]

Industry Pharmaceutical Preparations
Founded 1954
Employees 152
Stock Exchange Dhaka Stock Exchange
Ticker Symbol IBP
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.